GlassScriptPhysician profile
Carol Burnette
NPI 1538102611
$1,495.50
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $427 · 2021: $347 · 2022: $16.89.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $516.10 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $180.87 | 2019-2021 | |
| Pacira Therapeutics, INC. | $152.60 | 2019-2021 | |
| Forte Bio-Pharma LLC | $101.41 | 2019-2021 | |
| Nevro Corp. | $99.10 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $78.60 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $65.82 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.63 | 2020-2021 | |
| Medtronic USA, INC. | $56.61 | 2019 | |
| Collegium Pharmaceutical, INC. | $40.07 | 2019-2021 | |
| Ibsa Pharma INC. | $27.18 | 2021 | |
| Redhill Biopharma INC. | $25.79 | 2021 | |
| Virtus Pharmaceuticals LLC | $19.42 | 2021 | |
| Spinal Simplicity, LLC | $16.89 | 2022 | |
| Medtronic, INC. | $16.45 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.11 | 2020 | |
| Mdd US Operations, LLC | $12.42 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.43 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Burnette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.